Package 61703-319-22

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 61703-319-22
Digits Only 6170331922
Product NDC 61703-319
Product ID 61703-319_2af445e4-993f-4fec-a276-c01ff2451e92
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (61703-319-22) / 20 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 1999-11-22
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

Cytarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "2af445e4-993f-4fec-a276-c01ff2451e92", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["249364"], "spl_set_id": ["277597b0-7d85-40a3-a34a-70c6a883fc6d"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61703-319-22)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "61703-319-22", "marketing_start_date": "19991122"}], "brand_name": "Cytarabine", "product_id": "61703-319_2af445e4-993f-4fec-a276-c01ff2451e92", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "61703-319", "generic_name": "CYTARABINE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "100 mg/mL"}], "application_number": "ANDA075383", "marketing_category": "ANDA", "marketing_start_date": "19991122", "listing_expiration_date": "20261231"}